[ { "@graph" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU", "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ], "http://www.nanopub.org/nschema#hasAssertion" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#assertion" } ], "http://www.nanopub.org/nschema#hasProvenance" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#provenance" } ], "http://www.nanopub.org/nschema#hasPublicationInfo" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#pubInfo" } ] } ], "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#Head" }, { "@graph" : [ { "@id" : "http://identifiers.org/ncbigene/3949", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalEntity" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "LDL" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalEntity" } ] }, { "@id" : "http://identifiers.org/pubchem.compound/5997", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalEntity" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "cholesterol" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalEntity" } ] }, { "@id" : "http://identifiers.org/pubchem.compound/60823", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalEntity" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Atorvastatin" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalEntity" } ] }, { "@id" : "http://identifiers.org/umls/C0570410", "@type" : [ "https://w3id.org/biolink/vocab/ChemicalEntity" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "Statins" }, { "@value" : "statins" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/ChemicalEntity" } ] }, { "@id" : "http://purl.obolibrary.org/obo/MONDO_0002525", "@type" : [ "https://w3id.org/biolink/vocab/DiseaseOrPhenotypicFeature" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "dyslipidemia" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/DiseaseOrPhenotypicFeature" } ] }, { "@id" : "http://purl.obolibrary.org/obo/MONDO_0004995", "@type" : [ "https://w3id.org/biolink/vocab/DiseaseOrPhenotypicFeature" ], "http://www.w3.org/2000/01/rdf-schema#label" : [ { "@value" : "CVD" }, { "@value" : "cardiovascular diseases" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/DiseaseOrPhenotypicFeature" } ] }, { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#_1", "@type" : [ "https://w3id.org/biolink/vocab/Association" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/MONDO_0004995" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://identifiers.org/pubchem.compound/60823" } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ { "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Association" } ], "https://w3id.org/biolink/vocab/publications" : [ { "@id" : "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32" } ] }, { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#_2", "@type" : [ "https://w3id.org/biolink/vocab/Association" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://identifiers.org/pubchem.compound/5997" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/associated_with" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://purl.obolibrary.org/obo/MONDO_0004995" } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ { "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Association" } ], "https://w3id.org/biolink/vocab/publications" : [ { "@id" : "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32" } ] }, { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#_3", "@type" : [ "https://w3id.org/biolink/vocab/Association" ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ { "@id" : "http://purl.obolibrary.org/obo/MONDO_0002525" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ { "@id" : "https://w3id.org/biolink/vocab/treats" } ], "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ { "@id" : "http://identifiers.org/pubchem.compound/60823" } ], "https://w3id.org/biolink/vocab/aggregator_knowledge_source" : [ { "@id" : "https://w3id.org/biolink/infores/knowledge-collaboratory" } ], "https://w3id.org/biolink/vocab/category" : [ { "@id" : "https://w3id.org/biolink/vocab/Association" } ], "https://w3id.org/biolink/vocab/publications" : [ { "@id" : "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ae7c54b1-b440-4cca-97e8-e5b825413d32" } ] } ], "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#assertion" }, { "@graph" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#assertion", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2022-10-13T12:35:21.230396" } ], "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-3668-2627" } ], "http://www.w3.org/ns/prov#wasQuotedFrom" : [ { "@value" : " Atorvastatin and other statins are considered first-line treatment options for dyslipidemia. The increasing use of this class of drugs is largely attributed to the rise in cardiovascular diseases (CVD) An elevated cholesterol level (elevated low-density lipoprotein (LDL) levels) is a significant risk factor for the development of CVD. Statins were shown to reduce the incidences of all-cause mortality, including fatal and non-fatal CVD, as well as the need for surgical revascularization or angioplasty following a" } ] }, { "@id" : "https://w3id.org/biolink/vocab/", "http://purl.org/pav/version" : [ { "@value" : "2.3.0" } ] } ], "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#provenance" }, { "@graph" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU", "http://www.w3.org/ns/prov#generatedAtTime" : [ { "@type" : "http://www.w3.org/2001/XMLSchema#dateTime", "@value" : "2022-10-13T12:35:21.230396" } ], "http://www.w3.org/ns/prov#wasAttributedTo" : [ { "@id" : "https://orcid.org/0000-0002-3668-2627" } ] }, { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#sig", "http://purl.org/nanopub/x/hasAlgorithm" : [ { "@value" : "RSA" } ], "http://purl.org/nanopub/x/hasPublicKey" : [ { "@value" : "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" } ], "http://purl.org/nanopub/x/hasSignature" : [ { "@value" : "F40zk/co0p7hBtTcctGxpo+87Kg8Pd7CDOQb+Tac/oMtc9OlspkxUU2hfzi4VHm7CTLhhz2Ag0EcNNbVUKwvDCDOZtLvZWXNQkF/SoNQR9vQkaShAOmVndQtccuOzE/NugmJXRIqKxbYjajt9QSDNx3mdoO/lb9vMZBU/WTx+DaeFJnTxa6DfUAdCGsif/TIRu3QQtaQBaZhYWHRgFiUYLlzgTqi/eQdcjDF06zk1r1PJ3N42+Bpetsk6Ji5xJFh122slp+ZhEr3MAOJz+ddQtQpAt63QtXBjBSaz9upcWz33C8o7MK73uvt1uJ0BZV5t519NVzy/UPOGbpjN7afjg==" } ], "http://purl.org/nanopub/x/hasSignatureTarget" : [ { "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU" } ] } ], "@id" : "http://purl.org/np/RApHsKFnbSdWEl86GviCOj-qg9IDUR9AvvMRF8bO4DHLU#pubInfo" } ]